[ad_1]
The CEO of the world’s largest vaccine manufacturer, the Serum Institute of India, admits that, at best, the COVID-19 vaccine will reach the entire world’s population by the end of 2024.
Adar Poonawalla designed Financial times that pharmaceutical companies are not increasing production capacity fast enough to vaccinate the world’s population in less time.
It will be four to five years before everyone on the planet receives the vaccine “he said, explaining that if the vaccine for covid-19 has two doses, as is the case, for example, of the vaccine against measles or rotavirus, the world will need 15 billion doses.
The Serum Institute, located in the Indian city of Pune, has signed agreements with five pharmaceutical companies to develop a vaccine for COVID-19 and has committed to producing one billion doses, half of which will go to India.
I know the world wants to be optimistic, but I didn’t hear anyone approach this level right now. “said Poonawalla ao Financial times.
The Indian manufacturer will also be close to reaching an agreement with Russia to produce the Sputnik vaccine.
Under the agreement with the pharmaceutical company AstraZeneca, which is currently conducting clinical trials for the vaccine developed by the University of Oxford, the Serum Institute aims to produce vaccines that cost three dollars a dose (about 2.5 euros). to 68 countries. The agreement with Novavax provides for the production of vaccines for 92 countries.
The Serum Institute is the world’s largest manufacturer in terms of volume, producing 1.5 billion doses per year for more than 170 countries around the world against diseases such as polio, influenza, or measles.
HE Financial times He points out that the statements of the head of the Serum Institute cast serious doubts on the promises of politicians that guarantee vaccines until the end of this year. And that, likely, large orders from developed countries in the United States and Europe will leave developing economies with less purchasing power until the end of the line.
